Steroid breakthrough raises virus hopes despite fresh outbreak

From Sardar Shahab

LONDON: Britain is to start giving seriously ill coronavirus patients a basic steroid treatment hailed as a “major breakthrough” Tuesday capable of reducing the global pandemic’s death toll as worrying new outbreaks surfaced.
A new and “extremely severe” cluster of cases in Beijing cast doubt over efforts to get the virus under control although the news from Britain came as a boost after months of grim statistics. Federal Reserve Chair Jerome Powell meanwhile warned that the huge US economy is unlikely to recover as long as “significant uncertainty” remains over the course of the pandemic.
Researchers led by a team from the University of Oxford administered the widely available steroid dexamethasone to more than 2,000 severely ill COVID-19 patients. Among those who could only breathe with the help of a ventilator, dexamethasone reduced deaths by 35 percent.
“Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result,” said Peter Horby, professor of Emerging Infectious Diseases in the Nuffield Department of Medicine, University of Oxford.
“Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide.”
Britain’s Health Secretary Matt Hancock said patients would start to receive the drug immediately. The US central bank chief once again pledged the Fed will use all of its policy tools to help ensure recovery from the outbreak which he said has inflicted the worst pain on low-income and minority groups.
Despite a surprising rebound in employment in May, the US economy has shed nearly 20 million jobs since February and the contraction of GDP in the April-June quarter “is likely to be the most severe on record,” Powell said. Even with some promising data, “the levels of output and employment remain far below their pre-pandemic levels, and significant uncertainty remains about the timing and strength of the recovery,” he cautioned.
More than eight million people have now been infected by the virus worldwide since it first emerged in China late last year, claiming 436,813 lives so far as the tolls still surge in Latin America and South Asia. In Europe, caseloads and death rates have broadly declined.
The UK, however, is still struggling with the world’s third largest death toll and New Zealand which had ended community transmission said two new cases reported there were recent arrivals from Britain. European countries are eager to drop coronavirus restrictions to save the imminent summer tourist season but Spain warned that it may quarantine British visitors should the UK persist with its plan to quarantine all overseas arrivals.
The latest reminder of the underlying threat came from China, which had largely brought its outbreak under control, as 27 infections were reported in Beijing, where a new cluster linked to a wholesale food market has sparked mass testing and neighbourhood lockdowns.
“The epidemic situation in the capital is extremely severe,” Beijing city spokesman Xu Hejian warned, as the number of confirmed infections soared to 106.
While these cases have caused concern about a resurgence of the virus, the disease is also gaining momentum in other regions with massive populations.
Known infections in India have crossed 330,000 and already stretched authorities are bracing for the monsoon season, which causes outbreaks of other illnesses such as dengue fever and malaria every year. Vidya Thakur, medical superintendent at Mumbai’s Rajawadi Hospital, is used to managing “heavy burdens”, she says.